These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 24165482)

  • 1. A novel regulatory mechanism of Pim-3 kinase stability and its involvement in pancreatic cancer progression.
    Zhang F; Liu B; Wang Z; Yu XJ; Ni QX; Yang WT; Mukaida N; Li YY
    Mol Cancer Res; 2013 Dec; 11(12):1508-20. PubMed ID: 24165482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pim-3, a proto-oncogene with serine/threonine kinase activity, is aberrantly expressed in human pancreatic cancer and phosphorylates bad to block bad-mediated apoptosis in human pancreatic cancer cell lines.
    Li YY; Popivanova BK; Nagai Y; Ishikura H; Fujii C; Mukaida N
    Cancer Res; 2006 Jul; 66(13):6741-7. PubMed ID: 16818649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T-18, a stemonamide synthetic intermediate inhibits Pim kinase activity and induces cell apoptosis, acting as a potent anticancer drug.
    Wang Z; Li XM; Shang K; Zhang P; Wang CF; Xin YH; Zhou L; Li YY
    Oncol Rep; 2013 Mar; 29(3):1245-51. PubMed ID: 23314349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pim-3 promotes human pancreatic cancer growth by regulating tumor vasculogenesis.
    Liu B; Wang Z; Li HY; Zhang B; Ping B; Li YY
    Oncol Rep; 2014 Jun; 31(6):2625-34. PubMed ID: 24789328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-377 inhibits the proliferation of pancreatic cancer by targeting Pim-3.
    Chang W; Liu M; Xu J; Fu H; Zhou B; Yuan T; Chen P
    Tumour Biol; 2016 Nov; 37(11):14813-14824. PubMed ID: 27638830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of oncogenic Pim-3 kinase modulates transformed growth and chemosensitizes pancreatic cancer cells to gemcitabine.
    Xu D; Cobb MG; Gavilano L; Witherspoon SM; Williams D; White CD; Taverna P; Bednarski BK; Kim HJ; Baldwin AS; Baines AT
    Cancer Biol Ther; 2013 Jun; 14(6):492-501. PubMed ID: 23760491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pim-3 promotes the growth of human pancreatic cancer in the orthotopic nude mouse model through vascular endothelium growth factor.
    Wang C; Li HY; Liu B; Huang S; Wu L; Li YY
    J Surg Res; 2013 Dec; 185(2):595-604. PubMed ID: 23845873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of stemonamide synthetic intermediates as a novel potent anticancer drug with an apoptosis-inducing ability.
    Li YY; Wang YY; Taniguchi T; Kawakami T; Baba T; Ishibashi H; Mukaida N
    Int J Cancer; 2010 Jul; 127(2):474-84. PubMed ID: 19921695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathophysiological roles of Pim-3 kinase in pancreatic cancer development and progression.
    Li YY; Mukaida N
    World J Gastroenterol; 2014 Jul; 20(28):9392-404. PubMed ID: 25071334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pim-3 contributes to radioresistance through regulation of the cell cycle and DNA damage repair in pancreatic cancer cells.
    Chen XY; Wang Z; Li B; Zhang YJ; Li YY
    Biochem Biophys Res Commun; 2016 Apr; 473(1):296-302. PubMed ID: 27016481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The kinase Mirk/Dyrk1B mediates cell survival in pancreatic ductal adenocarcinoma.
    Deng X; Ewton DZ; Li S; Naqvi A; Mercer SE; Landas S; Friedman E
    Cancer Res; 2006 Apr; 66(8):4149-58. PubMed ID: 16618736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knockdown of Pim-3 suppresses the tumorigenicity of glioblastoma by regulating cell cycle and apoptosis.
    Quan J; Zhou L; Qu J
    Cell Mol Biol (Noisy-le-grand); 2015 Mar; 61(1):42-50. PubMed ID: 25817345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PIM kinases: an overview in tumors and recent advances in pancreatic cancer.
    Xu J; Zhang T; Wang T; You L; Zhao Y
    Future Oncol; 2014 Apr; 10(5):865-76. PubMed ID: 24799066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roles of Pim-3, a novel survival kinase, in tumorigenesis.
    Mukaida N; Wang YY; Li YY
    Cancer Sci; 2011 Aug; 102(8):1437-42. PubMed ID: 21518143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stabilization and enhancement of the antiapoptotic activity of mcl-1 by TCTP.
    Liu H; Peng HW; Cheng YS; Yuan HS; Yang-Yen HF
    Mol Cell Biol; 2005 Apr; 25(8):3117-26. PubMed ID: 15798198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant expression of serine/threonine kinase Pim-3 in hepatocellular carcinoma development and its role in the proliferation of human hepatoma cell lines.
    Fujii C; Nakamoto Y; Lu P; Tsuneyama K; Popivanova BK; Kaneko S; Mukaida N
    Int J Cancer; 2005 Mar; 114(2):209-18. PubMed ID: 15540201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of c-kit expression in pancreatic adenocarcinoma: a novel stem cell marker responsible for the progression of the disease.
    Amsterdam A; Raanan C; Polin N; Melzer E; Givol D; Schreiber L
    Acta Histochem; 2014 Jan; 116(1):197-203. PubMed ID: 23978330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pim-2 upregulation: biological implications associated with disease progression and perinueral invasion in prostate cancer.
    Dai H; Li R; Wheeler T; Diaz de Vivar A; Frolov A; Tahir S; Agoulnik I; Thompson T; Rowley D; Ayala G
    Prostate; 2005 Nov; 65(3):276-86. PubMed ID: 16015593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of polo-like kinase 1 and its clinical significance in human non-small cell lung cancer.
    Wang ZX; Xue D; Liu ZL; Lu BB; Bian HB; Pan X; Yin YM
    Int J Biochem Cell Biol; 2012 Jan; 44(1):200-10. PubMed ID: 22064247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-apoptotic protein TCTP controls the stability of the tumor suppressor p53.
    Rho SB; Lee JH; Park MS; Byun HJ; Kang S; Seo SS; Kim JY; Park SY
    FEBS Lett; 2011 Jan; 585(1):29-35. PubMed ID: 21081126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.